Jump to content

Norgesic

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Ralphroug (talk | contribs) at 14:31, 29 May 2017 (See the leaflet for Australia, the aspirin and caffeine are replaced, I think by Australian equivalent of Tylenol in U.S. This could be of some medical consequence for some people, I don't know if I did the citation right.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Norgesic
Clinical data
AHFS/Drugs.comMicromedex Detailed Consumer Information
MedlinePlusa682162
Routes of
administration		Oral
  (verify)

Norgesic is the brand name of a muscle relaxant. The generic is a combination of 385 mg of aspirin and 25 mg of orphenadrine citrate.[1]

It is available in Scandinavia, Austria, Greece, Thailand and Australia, but has been discontinued in some other countries.

In Australia it is a different combination of ingredients: Orphenadrine citrate 35mg & Paracetamol 450mg, no aspirin or caffeine, different side effects; see the [2] http://www.news-medical.net/drugs/Norgesic.aspxCite error: There are <ref> tags on this page without content in them (see the help page).leaflet published for Australia (http://www.news-medical.net/drugs/Norgesic.aspx)

Norgesic is made in Australia by: iNova Pharmaceuticals; (Aust) Pty Ltd; L10, 12 Help Street; Chatswood NSW 2067; Australian Registration Number: AUST R 10574 (bottles); AUST R 156623 (blister)*; This leaflet was prepared in December 2013; * Not currently marketed in Australia. 

It is also used in Hong Kong.[citation needed]

References

  1. ^ Norgesic at drugs.com
  2. ^ News Medical Life Sciences
Stub icon

This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Norgesic&oldid=782840233"